Company intelligence / Profile preview

Synkem

Chenôve, Burgundy-Franche-Comté, France

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Synkem is a Contract Development and Manufacturing Organization (CDMO) specializing in the process development and production of complex active pharmaceutical ingredients (APIs) and advanced intermediates. Originally established as a research and development center for Hoechst Marion Roussel, the company was acquired by the PCAS Group in 1999 and subsequently became part of the Seqens group (formerly Novacap) following the acquisition of PCAS in 2017. The facility is recognized for its expertise in multi-step organic synthesis and high-potency chemical processes.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Synkem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synkem.

Explore the full profile